Aspirin use associated with lower risk of cancer death for men with prostate cancer

	Tweet

Men with prostate cancer who take anticoagulants like aspirin in addition to radiation therapy or surgery may be able to cut their risk of dying of the disease by more than half, according to a large study presented on November 3, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego. The study involved more than 5,000 men with localized cancer whose disease had not spread beyond the prostate gland.

“Evidence has shown that anticoagulants may interfere with cancer growth and spread,” Kevin Choe, M.D., Ph.D., lead author of the study and a radiation oncologist at University of Texas Southwestern Medical School in Dallas, said. “If the major effect of anticoagulants is preventing metastasis (the ability of cancer cells to spread to other parts of the body), this may be why previous clinical trials with anticoagulation medications produced mixed results, since most patients in these trials already had metastasis. If the cancer has already metastasized, then anticoagulants may not be as beneficial.”

Researchers evaluated data from the Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE) database to investigate the effect of anticoagulation medications (aspirin, warfarin, clopidogrel and/or enoxaparin) on the risk of dying from prostate cancer among men whose cancer has not metastasized.

The study involved 5,275 men whose cancer had not spread beyond the prostate gland (localized prostate cancer) and were treated with surgery or radiation, two of the most common treatment modalities for prostate cancer. Of these patients, 1,982 were taking anticoagulants. Patients were classified as having high-, intermediate- or low-risk disease.

Results of the study show that the use of anticoagulants among prostate cancer patients treated with either surgery or radiation reduced the risk of dying from the disease from 10 percent to 4 percent at 10 years. The risk of developing bone metastasis was also reduced. In addition, findings reveal that the benefit appeared even greater among patients diagnosed with high-risk prostate cancer. This is exciting news as patients with high-risk disease have the most aggressive cancer, with a high likelihood of dying from the disease, and the treatment options are currently limited.

The study also found that the benefit was most prominent with aspirin, compared to other anticoagulants.

Choe said, “Findings from this study are promising, however, further studies are necessary before the addition of aspirin to prostate cancer therapy becomes standard treatment.”

###

For more information on radiation therapy for prostate cancer, visit http://www.rtanswers.org.

The abstract, “Aspirin Use and the Risk of Prostate Cancer Death in Men Treated with Prostatectomy or Radiotherapy: Results from the CaPSURE Database,” will be presented at a scientific session at 1:45 p.m. on Wednesday, November 3, 2010. To speak to the lead author of the study, Kevin Choe, M.D., Ph.D., please call Beth Bukata or Nicole Napoli on October 31 – November 2, 2010, in the ASTRO Press Room at the San Diego Convention Center at 619-525-6313 or 619-525-6314. You may also e-mail them at or .

###
Contact: Beth Bukata

703-839-7332
American Society for Radiation Oncology

RELATED STORIES:
Genetic Link Uncovered in Disparate Colon Cancer Death   Western and Japanese diets up colon cancer risk   Preventing bowel cancer in high risk families   Celebrex may curb colon cancer, but with caveats   Aspirin Or NSAIDs Won’t Prevent Colorectal Cancer   Magnesium may curb colon cancer risk in women   Can a Cholesterol Drug Prevent Colon Cancer?   Regular, long-term aspirin use reduces risk of colorectal cancer   How to Lower Costs, Waiting Times for Colonoscopies   The cellular root of colorectal cancers?   Poor colonoscopy prep hides pre-cancerous polyps   Sibling Study Could Lead to Better Treatments for Inherited Form of Colon Cancer   Program Identifies Families at High Risk for Colorectal Cancer   Chemicals in curry and onions may help prevent colon cancer   Colorectal Cancer More Common Among Diabetics   Virtual colonoscopy an effective colorectal cancer screening exam in Medicare age patientsComputed t   Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium   Post-Treatment Diet Patterns Explored in Colorectal Cancer Patients   Women on bone drugs have less colon cancer: study   Biomarker Predicts Disease Recurrence in Colorectal Cancer   Studies lend insights into colorectal cancer screening   Exercise, diet may protect against colorectal cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]